Global Assets Advisory LLC Increases Holdings in UnitedHealth Group Incorporated (NYSE:UNH)

Global Assets Advisory LLC boosted its position in shares of UnitedHealth Group Incorporated (NYSE:UNH - Free Report) by 180.6% in the 1st quarter, according to its most recent disclosure with the Securities & Exchange Commission. The firm owned 3,199 shares of the healthcare conglomerate's stock after buying an additional 2,059 shares during the quarter. Global Assets Advisory LLC's holdings in UnitedHealth Group were worth $1,762,000 as of its most recent filing with the Securities & Exchange Commission.

A number of other hedge funds have also bought and sold shares of UNH. NewSquare Capital LLC purchased a new stake in UnitedHealth Group in the 4th quarter valued at about $25,000. Marshall & Sterling Wealth Advisors Inc. bought a new position in shares of UnitedHealth Group during the 4th quarter worth $26,000. Hurley Capital LLC bought a new stake in shares of UnitedHealth Group in the fourth quarter valued at about $28,000. Aster Capital Management DIFC Ltd bought a new stake in shares of UnitedHealth Group in the 4th quarter valued at about $30,000. Finally, Promus Capital LLC bought a new position in shares of UnitedHealth Group during the fourth quarter valued at approximately $32,000. Institutional investors own 87.86% of the company's stock.

Insiders Place Their Bets

In related news, Director Timothy Patrick Flynn bought 1,533 shares of the business's stock in a transaction dated Wednesday, May 14th. The stock was acquired at an average price of $320.80 per share, with a total value of $491,786.40. Following the completion of the purchase, the director now directly owns 6,033 shares of the company's stock, valued at approximately $1,935,386.40. This trade represents a 34.07% increase in their ownership of the stock. The purchase was disclosed in a document filed with the SEC, which is available through the SEC website. Also, CEO Patrick Hugh Conway sold 589 shares of UnitedHealth Group stock in a transaction dated Tuesday, June 10th. The stock was sold at an average price of $305.00, for a total value of $179,645.00. Following the completion of the sale, the chief executive officer now owns 10,398 shares in the company, valued at approximately $3,171,390. The trade was a 5.36% decrease in their ownership of the stock. The disclosure for this sale can be found here. Over the last 90 days, insiders have acquired 109,408 shares of company stock worth $31,607,768. 0.28% of the stock is owned by corporate insiders.

Wall Street Analyst Weigh In

A number of equities research analysts recently weighed in on the company. Hsbc Global Res cut UnitedHealth Group from a "hold" rating to a "moderate sell" rating in a research note on Wednesday, May 21st. Barclays lowered their price target on shares of UnitedHealth Group to $350.00 and set an "overweight" rating on the stock in a report on Monday, June 2nd. Baird R W downgraded shares of UnitedHealth Group from a "strong-buy" rating to a "hold" rating in a research note on Wednesday, June 11th. TD Cowen lowered UnitedHealth Group from a "buy" rating to a "hold" rating and set a $308.00 price objective for the company. in a report on Monday, May 19th. Finally, Truist Financial reaffirmed a "buy" rating and set a $360.00 target price (down from $580.00) on shares of UnitedHealth Group in a research report on Monday, May 19th. One equities research analyst has rated the stock with a sell rating, nine have assigned a hold rating and sixteen have assigned a buy rating to the stock. Based on data from MarketBeat, UnitedHealth Group presently has a consensus rating of "Moderate Buy" and an average target price of $415.57.

UnitedHealth Group Stock Performance

UNH traded up $0.41 during midday trading on Thursday, hitting $302.43. 6,497,799 shares of the company were exchanged, compared to its average volume of 7,416,648. UnitedHealth Group Incorporated has a 1-year low of $248.88 and a 1-year high of $630.73. The company has a current ratio of 0.85, a quick ratio of 0.85 and a debt-to-equity ratio of 0.71. The firm has a market capitalization of $274.35 billion, a price-to-earnings ratio of 12.66, a price-to-earnings-growth ratio of 1.45 and a beta of 0.44. The company's 50 day simple moving average is $342.22 and its 200 day simple moving average is $458.07.

UnitedHealth Group (NYSE:UNH - Get Free Report) last announced its quarterly earnings results on Thursday, April 17th. The healthcare conglomerate reported $7.20 earnings per share (EPS) for the quarter, missing analysts' consensus estimates of $7.29 by ($0.09). The company had revenue of $109.58 billion during the quarter, compared to analyst estimates of $111.56 billion. UnitedHealth Group had a net margin of 5.39% and a return on equity of 26.29%. During the same period in the previous year, the firm posted $6.91 earnings per share. As a group, sell-side analysts predict that UnitedHealth Group Incorporated will post 29.54 earnings per share for the current year.

UnitedHealth Group Increases Dividend

The firm also recently declared a quarterly dividend, which was paid on Tuesday, June 24th. Investors of record on Monday, June 16th were paid a $2.21 dividend. This represents a $8.84 annualized dividend and a dividend yield of 2.92%. The ex-dividend date of this dividend was Monday, June 16th. This is a positive change from UnitedHealth Group's previous quarterly dividend of $2.10. UnitedHealth Group's payout ratio is currently 37.02%.

UnitedHealth Group Company Profile

UnitedHealth Group Incorporated operates as a diversified health care company in the United States. The company operates through four segments: UnitedHealthcare, Optum Health, Optum Insight, and Optum Rx. The UnitedHealthcare segment offers consumer-oriented health benefit plans and services for national employers, public sector employers, mid-sized employers, small businesses, and individuals; health care coverage, and health and well-being services to individuals age 50 and older addressing their needs; Medicaid plans, children's health insurance and health care programs; and health and dental benefits, and hospital and clinical services, as well as health care benefits products and services to state programs caring for the economically disadvantaged, medically underserved, and those without the benefit of employer-funded health care coverage.